| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 3,731 | 3,574 | 3,000 | 3,688 | | Selling General and Administrative | 2,012 | 2,183 | 2,179 | 2,050 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,742) | (5,757) | (5,179) | (5,738) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1 | 38 | 10 | | Earnings Before Interest And Taxes | (5,746) | (5,757) | (5,142) | (5,728) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,746) | (5,757) | (5,142) | (5,728) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,746) | (5,757) | (5,142) | (5,728) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,746) | (5,757) | (5,142) | (5,728) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,746) | ($5,757) | ($5,142) | ($5,728) |
|
0.03% Nasdaq 
Income Statement
